BELLEVUE GROUP AG – Inhibrx Biosciences, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$781,000
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+58.15%
quarter
Inhibrx Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -43.21% | -33.1K shares | -88K | $17.95 | 43.5K |
| Q2 2022 | share | Increase | +54.12% | 26.9K shares | -238K | $11.35 | 76.6K |
| Q1 2022 | share | Decrease | -1.58% | -800 shares | -1.09M | $22.28 | 49.7K |
| Q4 2021 | share | Increase | 0.00% | 50.5K shares | 2.20M | $43.06 | 50.5K |